Paget's disease of the breast differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 21: Line 21:


Paget's disease of the breast is often misdiagnosed as nipple eczema   
Paget's disease of the breast is often misdiagnosed as nipple eczema   
{|
{|
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
Line 26: Line 27:
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! rowspan="2" |Para-clinical findings
! rowspan="2" |Para-clinical findings
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors'''
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors'''
|-
|-
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
|-
|-
Line 39: Line 40:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple Discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple Discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Erythema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Erythema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Involved areas
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast Exam
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast Exam
Line 51: Line 51:
| align="center" style="background:#F5F5F5;" |Serous or bloody [[nipple discharge]] may be present.
| align="center" style="background:#F5F5F5;" |Serous or bloody [[nipple discharge]] may be present.
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |Breast
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |appearance varies from small flaps to well-delimited erythematous and desquamative plaques with irregular borders
| align="center" style="background:#F5F5F5;" |
* Well-demarcated [[erythematous]] and [[Desquamation|desquamative plaques]] with irregular borders seen.
* [[Breast lump]] palpated in >50% cases.
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 62: Line 63:
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Extramammary Paget's disease]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Extramammary Paget's disease]]
| align="center" style="background:#F5F5F5;" |[[Malignant]]
| align="center" style="background:#F5F5F5;" |[[Malignant]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 87: Line 87:
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Young children -[[Scalp]], [[cheeks]] amd [[extensor]] surface
 
* [[Adolescent|Adolescents]] -flexural areas and buttock-thigh creases
* Adults - facial involvement and skin flexures
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Usually bilateral, no accompanying induration
* Usually bilateral, nipple with no accompanying induration.
| align="center" style="background:#F5F5F5;" |
* Centrofacial pallor
* Centrofacial pallor
* Delayed blanch response
* Delayed blanch response
Line 100: Line 97:
* [[Pityriasis alba]]
* [[Pityriasis alba]]
* [[Ichthyosis]]
* [[Ichthyosis]]
* Infra-auricular and retro-auricular fissuring
* Nipple [[eczema]]
* White dermographism
* Perifollicular accentuation
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Epidermal psoriasiform [[hyperplasia]]
* Epidermal psoriasiform [[hyperplasia]]
Line 111: Line 104:
* [[Dyskeratosis congenita|Dyskeratosis]]
* [[Dyskeratosis congenita|Dyskeratosis]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*
* [[Family history]] of  [[atopy]]
* [[Family history]] of  [[atopy]]
* History of [[Breast implants|silicon implants]] or [[Breast reconstruction|reconstruction]] of nipple areola complex or [[lactation]].
* History of [[Breast implants|silicon implants]] or [[Breast reconstruction|reconstruction]] of nipple areola complex or [[lactation]].
Line 129: Line 122:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Nipple]] may have [[Granuloma|granulomatous lesion]] .
* granulomatous-looking lesion will be seen on the nipple.
* A [[nodule]] either within or under the [[nipple]] adherent to the [[skin]], but not the [[breast]] may be palpated.  
* a nodule either within or under the nipple may be palpated.Which adheres to the skin, but is freely movable over the breast.
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Insidious onset.
* Insidious onset.
* No  [[lymphadenopathy]].
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Papillomatous pattern: [[vascular]] papillae project into dilated [[lumina]] and are surrounded by [[Epithelial cells|proliferating epithelial cells]] .
* [[Papilla|Papillary]] pattern:  [[cells]] proliferate into large cords with deep fissures and clefts and dense [[stroma]].
| align="center" style="background:#F5F5F5;" |[[Biopsy]]
| align="center" style="background:#F5F5F5;" |[[Biopsy]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Incidence]] is highest in the fifth decade in women.
* [[Incidence]] is highest in the fifth decade in women.
* No  [[lymphadenopathy]].
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref>
Line 147: Line 144:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 157: Line 153:
* [[Eosinophilic]] spongiosis and [[microvesicles]]
* [[Eosinophilic]] spongiosis and [[microvesicles]]
* [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]]  
* [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]]  
* Chronic - [[Hyperkeratosis]] and parakeratosis
* Chronic - [[Hyperkeratosis]] and [[parakeratosis]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Contact with [[allergens]] in the past 1-2 days
* Contact with [[allergens]] in the past 1-2 days
Line 171: Line 168:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
* Scalp
| align="center" style="background:#F5F5F5;" |[[Auspitz's sign]]  (pinpoint bleeding)
* Trunk
* Gluteal cleft
* Extensor surface of elbows and knees
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Epidermal]] [[hyperplasia]]
* [[Auspitz's sign]] (pinpoint bleeding)
* Parakeratosis
* [[Neutrophils]] microabscesses (Munro microabscesses)
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Epidermal]] [[hyperplasia]]
* [[Epidermal]] [[hyperplasia]]
Line 185: Line 181:
* [[Neutrophils]] microabscesses (Munro microabscesses)
* [[Neutrophils]] microabscesses (Munro microabscesses)
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |Risk factors include
 
Risk factors include
* [[Smoking]]
* [[Smoking]]
* Skin trauma
* Skin trauma
Line 215: Line 212:
[[Bleeding]] from the lesion may be present
[[Bleeding]] from the lesion may be present
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* All [[UV radiation]]<nowiki/>or sun exposed areas can be effected independently
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 243: Line 238:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Fair-skinned individuals: sun-exposed areas
* In black individuals: legs, anus, and areas of chronic inflammation
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 271: Line 262:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Sun-exposed areas
* Head (cheek and nose)
* Trunk
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 290: Line 277:
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 304: Line 290:
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 321: Line 306:
| align="center" style="background:#F5F5F5;" |* Common among [[perimenopausal]]<nowiki/> women
| align="center" style="background:#F5F5F5;" |* Common among [[perimenopausal]]<nowiki/> women
* Usually resolve spontaneously
* Usually resolve spontaneously
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 335: Line 319:
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 349: Line 332:
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell  hyperplasia
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell  hyperplasia
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 364: Line 346:
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast abscess]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast abscess]]
| align="center" style="background:#F5F5F5;" |[[Benign]]
| align="center" style="background:#F5F5F5;" |[[Benign]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 381: Line 362:
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 398: Line 378:
* [[Benign]]
* [[Benign]]
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 420: Line 399:
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory Breast Cancer
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory Breast Cancer
| align="center" style="background:#F5F5F5;" |[[Malignant]]
| align="center" style="background:#F5F5F5;" |[[Malignant]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |

Revision as of 00:24, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]

Overview

Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]

Differential Diagnosis

Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]

Paget's disease of the breast is often misdiagnosed as nipple eczema

Category Diseases Benign or Malignant Etiology Clinical manifestations Para-clinical findings Gold Standard Associated factors
Symptoms Physical examination
Histopathology
Rash Nipple Discharge Erythema Mastalgia Breast Exam Other
Skin disorders Paget's disease of the breast Malignant Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region Serous or bloody nipple discharge may be present. +
Extramammary Paget's disease Malignant Biopsy
Atopic dermatitis

(Eczema)

  • Epidermal barrier dysfunction
  • Immune dysregulation
Erosive adenomatosis of the nipple
  • Benign
  • Neoplasm of breast lactiferous ducts
Eczema, crusts or erosion of nipple Serous or bloody nipple discharge.
  • Papillary pattern: cells proliferate into large cords with deep fissures and clefts and dense stroma.
Biopsy
Allergic contact dermatitis[3] Benign Erythematous well-demarcated papules +
Psoriasis Benign Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales + + Auspitz's sign (pinpoint bleeding)

Risk factors include

Malignant melanoma Malignant
  • Macule
  • Plaque with irregular border
  • Variable size
  • A lesion with ABCD
    • Asymmetry
    • Border irregularity
    • Color variation
    • Diameterchanges
  • Bleeding from the lesion

Bleeding from the lesion may be present

Bowen’s disease Benign can turn malignant
  • Erythematous
  • Skin colored
  • Patch
  • Plaque
  • scaly
  • variable size
  • Presence of dotted and/or glomerular vessels
  • White to yellowish surface scales
  • Red-yellowish background
  • Keratinocytic dysplasia of the epidermis
  • No infiltration into dermis
  • Pleomorphic keratinocytes
  • Hyperchromatic nuclei
  • Slow growth over the years
Superficial basal cell carcinoma Malignant
  • Erythematous
  • Superficial scaly patch
  • Superficial fine telangiectasia
  • Shiny white to red, translucent or opaque structureless areas
  • Multiple small erosions
  • Large, hyperchromatic, oval nuclei
  • Minimal cytoplasm
  • Small basaloid nodules
  • Higher incidence in men
Benign intraductal papilloma
Pagetoid dyskeratosis
Lactiferous duct ectasia Benign * Common among perimenopausal women
  • Usually resolve spontaneously
Ultrasound:
  • Dilated milk ducts
  • Fluid-filled ducts
Nipple duct adenoma
Benign Toker cell hyperplasia
Breast abscess Benign +

Ultrasound:

  • Fluid collection
Mondors disease
Mastitis ±

Breast parenchymainflammation:

Ultrasound:

  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
Inflammatory Breast Cancer Malignant Biopsy

References

  1. 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
  2. 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
  3. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.